Evolution of Novartis’ Small Molecule Screening Deck Design by Schuffenhauer, Ansgar, Schneider, Nadine, Hintermann, Samuel, Auld, Douglas, Blank, Jutta, Cotesta, Simona, Engeloch, Caroline, Fechner, Nikolas, Gaul, Christoph, Giovannoni, Jerome, Jansen, Johanna, Joslin, John, Krastel, Philipp, Lounkine, Eugen, Manchester, John, Monovich, Lauren G, Pelliccioli, Anna Paola, Schwarze, Manuel, Shultz, Michael D, Stiefl, Nikolaus, Baeschlin, Daniel K

Get full text

mRNA Display Identifies Potent, Paralog-Selective Peptidic Ligands for ARID1B by Cremosnik, Gregor S., Mesrouze, Yannick, Zueger, Patrik, Furkert, David, Grandjean, Frédéric, Argoti, Dayana, Mermet-Meillon, Fanny, Bauer, Matthias R., Brittain, Scott, Rogemoser, Phuong, Yang, Winnie, Giovannoni, Jerome, McGregor, Lynn, Tang, Jenny, Knapp, Mark, Holzinger, Sandra, Buhr, Sylvia, Muller, Lionel, Leder, Lukas, Xie, Lili, Fernandez, Cesar, Nieto-Oberhuber, Cristina, Chène, Patrick, Galli, Giorgio G., Sesterhenn, Fabian

Get full text

Abstract P124: JDQ443, a covalent irreversible inhibitor of KRAS G12C, exhibits a novel binding mode and demonstrates potent anti-tumor activity and favorable pharmacokinetic prope... by Brachmann, Saskia M., Weiss, Andreas, Guthy, Daniel A., Beyer, Kim, Voshol, Johannes, Maira, Michel, Prahallad, Anirudh, Porta, Diana Graus, Schnell, Christian, Ostermann, Nils, Vaupel, Andrea, Gerspacher, Marc, Leblanc, Catherine, Erdmann, Dirk, Sterker, Dario, Kerr, Grainne, Jerome, Giovannoni, Head, Victoria, Stringer, Rowan, De Kanter, Ruben, Jeff, Kearns, Roman, Danielle, Widmer, Toni, Wessels, Peter, Nunez, Eloisa Jimenez, Sedrani, Richard, Zecri, Frederic, Hofmann, Francesco, Engleman, Jeff, Lorthiois, Edwige, Cotesta, Simona

Get full text

Solid-phase synthesis of 3,7-disubstituted perhydro-1,4-diazepine-2,5-diones from amino acids and β-amino acids by Giovannoni, Jérôme, Subra, Gilles, Amblard, Muriel, Martinez, Jean

Get full text

Synthesis and Structure of Symmetrical Bicyclic Hexapeptides Bridged by Metathesis Reaction by Giovannoni, Jérôme, Didierjean, Claude, Durand, Philippe, Marraud, Michel, Aubry, André, Renaut, Patrice, Martinez, Jean, Amblard, Muriel

Get full text

The tomato genome sequence provides insights into fleshy fruit evolution by Tomato Genome Consortium, Sato, S, Guigó Serra, Roderic, Cámara, Francisco, Gianese, S

Get full text

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlle... by Foley, John F, Defer, Gilles, Ryerson, Lana Zhovtis, Cohen, Jeffrey A, Arnold, Douglas L, Butzkueven, Helmut, Cutter, Gary, Giovannoni, Gavin, Killestein, Joep, Wiendl, Heinz, Smirnakis, Karen, Xiao, Shan, Kong, George, Kuhelj, Robert, Campbell, Nolan, van der Walt, Anneke, Dwyer, Christopher, Buzzard, Katherine, Spies, Judith, Parratt, John, van Pesch, Vincent, Willekens, Barbara, Perrotta, Gaetano, Bartholomé, Emmanuel, Grand'Maison, Francois, Jacques, Francois, Giacomini, Paul, Vosoughi, Reza, Girard, Jean-Marc, de Seze, Jerome, Lebrun Frenay, Christine, Ruet, Aurelie, Laplaud, David-Axel, Reifschneider, Gerd, Wagner, Bert, Rauer, Sebastian, Pul, Refik, Seipelt, Maria, Berthele, Achim, Klotz, Luisa, Kallmann, Boris-Alexander, Paul, Friedemann, Achiron, Anat, Lus, Giacomo, Centonze, Diego, Patti, Francesco, Grimaldi, Luigi, Hupperts, Raymond, Frequin, Stephan, Fermont, Jiske, Madueno, Sara Eichau, Alonso Torres, Ana Maria, Costa-Frossard França, Lucienne, Meca-Lallana, Jose Eustasio, Ruiz, Luis Brieva, Pearson, Owen, Rog, David, Evangelou, Nikolaos, Ismail, Azza, Lathi, Ellen, Fox, Edward, Leist, Thomas, Sloane, Jacob, Wu, Gregory, Khatri, Bhupendra, Steingo, Brian, Thrower, Ben, Gudesblatt, Mark, Calkwood, Jonathan, Bandari, Daniel, Scagnelli, John, Laganke, Christopher, Robertson, Derrick, Kipp, Lucas, Belkin, Martin, Cohan, Stanley, Goldstick, Lawrence, Courtney, Ardith, Vargas, Wendy, Sylvester, Andrew, Srinivasan, Jayshri, Kannan, Meena, Picone, Maryann, English, Jeffrey, Napoli, Salvatore, Balabanov, Roumen, Zaydan, Islam, Nicholas, Jacqueline, Kaplan, Jeffrey, Lublin, Fred, Riser, Emily, Miller, Tamara, Alvarez, Enrique, Wray, Sibyl, Gross, Jeffrey, Pawate, Siddharama, Hersh, Carrie, McCarthy, Lucas, Crayton, Heidi, Graves, Jennifer

Get full text

152. Efficacy of Frexalimab on Physical and Psychological Impacts and Fatigue in Relapsing Multiple Sclerosis: Findings from MSIS-29v2 and PROMIS-Fatigue-MS-8a Assessments in a Pha... by Vermersch, Patrick, Saubadu, Stephane, Truffinet, Philippe, Arnould, Benoit, Hakimi-Hawken, Natalia, Minor, Charles, Araujo, Lita, Gourlain, Samuel, Msihid, Jerome, Giovannoni, Gavin

Get full text

Réduction à long terme du taux de poussées et de progression du handicap confirmée à 48 semaines (CDP48) après 6,5 ans de traitement par ocrelizumab (OCR) chez des patients atteint... by Giovannoni, Gavin, Kappos, Ludwig, De Sèze, Jérôme, Hauser, Stephen L., Köndgen, Harold, Schneble, Hans-Martin, Wolinsky, Jerry S.

Get full text

Réduction à long-terme du taux de poussées et de progression du handicap après 6 ans de traitement par ocrelizumab (OCR) chez des patients atteints de sclérose en plaques récurrent... by De Sèze, Jérôme, Giovannoni, Gavin, Kappos, Ludwig, Hauser, Stephen L., Köndgen, Harold, Prajapati, Kalpesh, Wolinsky, Jerry S.

Get full text

Efficacité et sécurité de l’ocrelizumab chez les patients atteints de sclérose en plaques primaire progressive : résultats d’ORATORIO, étude de phase III, en double-insu, contrôlée... by De Seze, Jérôme, Arnold, Douglas, Giovannoni, Gavin, Montalban, Xavier, Sauter, Annette, Chin, Peter, Wolinsky, Jerry

Get full text